These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 1458154)

  • 1. [The characteristics of the action of mildronate (dihydrate 3-(2,2,2-trimethylhydrazine)propionate) on the red blood parameters in heart failure].
    Sisetskiĭ AP; Artiukh VP; Sakharchuk II; Starodub NF
    Eksp Klin Farmakol; 1992; 55(3):20-1. PubMed ID: 1458154
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effects of mildronate on hemoglobin ligand spectrum in patients with ischemic heart disease complicated by coronary insufficiency].
    Sakharchuk II; Starodub NF; Sisetskiĭ AP; Artiukh VP; Denisenko GT
    Kardiologiia; 1990 Sep; 30(9):87-8. PubMed ID: 2273751
    [No Abstract]   [Full Text] [Related]  

  • 3. [Erythrocyte functional activity in patients with heart failure and the possible means for its correction].
    Sakharchuk II; Sisetskiĭ AP; Artiukh VP; Starodub NF
    Ter Arkh; 1992; 64(9):88-90. PubMed ID: 1481164
    [No Abstract]   [Full Text] [Related]  

  • 4. [The phosphate and methemoglobin content of the erythrocytes in patients with ischemic heart disease].
    Sisetskiĭ AP; Artiuk VP; Sakharchuk II; Starodub NF
    Vrach Delo; 1991 Mar; (3):19-22. PubMed ID: 2042338
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Biochemical mechanisms of mildronate action during ischemic stress].
    Dambrova M; Daĭia D; Liepin'sh E; Kir'ianova O; Kalvin'sh I
    Lik Sprava; 2004 Mar; (2):68-74. PubMed ID: 15208880
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The use of mildronat in heart failure in patients with chronic ischemic heart disease].
    Sakharchuk II; Denisenko GT; Grushko VS; Bodaretskaia OI; Pishchalenko AN
    Vrach Delo; 1989 Sep; (9):21-3. PubMed ID: 2609613
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The cardioprotective action of carnitine and its structural analog 3-(2,2,2-trimethylhydrazine)propionate on cardiac energy metabolism in experimental occlusion of the coronary artery in rats].
    Ratunova TM; Bauman VR; Kalvin'sh IIa
    Farmakol Toksikol; 1989; 52(5):24-7. PubMed ID: 2599072
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The effect of the new metabolic preparations rikavit and mildronat on the parameters of the blood acid-base balance in humans with hypoxia].
    Serebrovs'ka ZA; Denisenko HT; Serebrovs'ka TV
    Fiziol Zh (1978); 1992; 38(1):26-31. PubMed ID: 1555722
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Mildronate in combined treatment of chronic cardiac insufficiency].
    Nedoshivin AO; Kutuzova AE; Perepech NB
    Klin Med (Mosk); 1999; 77(3):41-3. PubMed ID: 10234947
    [No Abstract]   [Full Text] [Related]  

  • 10. [Effect of mildronate on life quality of patients with chronic heart failure].
    Nedoshivin AO; Petrova NN; Kutuzova AE; Perepech NB
    Ter Arkh; 1999; 71(8):10-2. PubMed ID: 10515026
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The use of mildronate in combined therapy of postinfarction chronic heart failure in patients with type 2 diabetes mellitus].
    Statsenko ME; Belenkova SV; Sporova OE; Shilina NN
    Klin Med (Mosk); 2007; 85(7):39-42. PubMed ID: 17882808
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The effect of mildronate on disorders of the cardiac contractile function in rats caused by an excess of free fatty acids and ischemia].
    Simkhovich BZ; Briede IaL; Ozola RA; Meĭrena DV; Kalvin'sh IIa; Lukevits EIa
    Farmakol Toksikol; 1990; 53(5):27-9. PubMed ID: 2253743
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mildronate: an antiischemic drug for neurological indications.
    Sjakste N; Gutcaits A; Kalvinsh I
    CNS Drug Rev; 2005; 11(2):151-68. PubMed ID: 16007237
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Isoptin in the therapy of supraventricular arrhythmia in patients with diabetes mellitus, non-insulin dependent, concurrent with ischemic heart disease].
    Potolochnaia MD; Burvalova GI; Pinchuk-Nikolaĭchuk VP
    Lik Sprava; 2001; (5-6):125-8. PubMed ID: 11881347
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mildronate: cardioprotective action through carnitine-lowering effect.
    Dambrova M; Liepinsh E; Kalvinsh I
    Trends Cardiovasc Med; 2002 Aug; 12(6):275-9. PubMed ID: 12242052
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The effect of diltiazem on the systemic hemodynamics of patients with heart failure due to ischemic heart disease].
    Koshlia EV
    Lik Sprava; 1998 Dec; (8):97-9. PubMed ID: 10204360
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Mildronate in geriatric patients with cardiac failure].
    Kalvinsh I; Visokinskas A; Bagdonas G; Knasene Iu; Lesaukaite V; Matsiyauskene Iu
    Ter Arkh; 2006; 78(9):75-7. PubMed ID: 17076229
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Efficiency of mildronate in rats of different age with experimental-induced myocardial ischemia].
    Kukes VG; Zhernakova NI; Gorbach TV; Romashchenko OV; Rumbesht VV
    Vestn Ross Akad Med Nauk; 2013; (1):42-6. PubMed ID: 23805638
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The use of fatty acid beta-oxidation inhibitor mildronate as monotherapy or in combination with atenolol in patients with left ventricular dysfunction after myocardial infarction].
    Teplyakov AT; Sankevitch TV; Stepatcheva TA; Mamchur SE
    Kardiologiia; 2003; 43(12):15-8. PubMed ID: 14671546
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The efficacy of the mildronate treatment of patients with ischemic stroke].
    Vinichuk SM
    Vrach Delo; 1991 Jul; (7):77-9. PubMed ID: 1771844
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.